AMEFX
Price
$25.14
Change
+$0.28 (+1.13%)
Updated
Jan 21 closing price
Net Assets
126.58B
FTASX
Price
$27.97
Change
+$0.29 (+1.05%)
Updated
Jan 21 closing price
Net Assets
6.86B
Ad is loading...

AMEFX vs FTASX

Header iconAMEFX vs FTASX Comparison
Open Charts AMEFX vs FTASXBanner chart's image
American Funds Income Fund of Amer F2
Price$25.14
Change+$0.28 (+1.13%)
VolumeN/A
Net Assets126.58B
Fidelity Advisor Asset Manager 70% M
Price$27.97
Change+$0.29 (+1.05%)
VolumeN/A
Net Assets6.86B
AMEFX vs FTASX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMEFX vs. FTASX commentary
Jan 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMEFX is a Buy and FTASX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
AMEFX has more cash in the bank: 127B vs. FTASX (6.86B). AMEFX pays higher dividends than FTASX: AMEFX (3.73) vs FTASX (1.14). AMEFX was incepted earlier than FTASX: AMEFX (16 years) vs FTASX (16 years). AMEFX is a more actively managed with annual turnover of: 40.00 vs. FTASX (19.00). FTASX has a lower initial minimum investment than AMEFX: FTASX (0) vs AMEFX (250). AMEFX annual gain was more profitable for investors over the last year : 13.24 vs. FTASX (10.49). FTASX return over 5 years is better than : 27.34 vs. AMEFX (21.68).
AMEFXFTASXAMEFX / FTASX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years16 years-
Gain YTD3.1172.529123%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets127B6.86B1,852%
Annual Yield % from dividends3.731.14328%
Returns for 1 year13.2410.49126%
Returns for 3 years8.906.77131%
Returns for 5 years21.6827.3479%
Returns for 10 years35.9448.4474%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FFFMX56.970.62
+1.10%
American Funds American Mutual 529-F-3
TAGDX13.96N/A
N/A
Transamerica Large Growth R6
RYCFX40.71N/A
N/A
Rydex Biotechnology C
GCTIX48.57N/A
N/A
Goldman Sachs US Tax-Managed Eq Instl
GSSUX41.63N/A
N/A
Goldman Sachs Small Cap Value R6